Bernard Macatangay
University of Pittsburgh
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bernard Macatangay as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03758625 · Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional CureSharon Riddler · completed · HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- University of Pittsburgh MWCCS Clinical Research SiteU01HL146208 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2026 · $1,502,431 awarded in 2026Same name and institution; not confirmed by an ID
- Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional CureU01AI131285 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2017 to 2021 · $1,184,950 awarded in 2021Grant number is on one of their registry trials
- Impact of Poor Sleep on Inflammation and the Adenosine Signaling Pathway in HIV InfectionR01HL142118 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2018 to 2021 · $495,862 awarded in 2021Same name and institution; not confirmed by an ID
- Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine RegulationU01AI110410 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2014 to 2017 · $652,643 awarded in 2017Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:00 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.Bull World Health Organ · 2003116 citationsRCR 3.9
- Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.J Clin Invest · 2019111 citationsRCR 5.1
- Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.Clin Infect Dis · 202298 citationsRCR 7.1
- The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.J Infect Dis · 201285 citationsRCR 2.4
- 66 citationsRCR 2.2
- A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy.J Infect Dis · 202144 citationsRCR 2.5
- Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells.J Infect Dis · 201643 citationsRCR 1.3
- A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.J Infect Dis · 202032 citationsRCR 1.8
- Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.Clin Infect Dis · 202332 citationsRCR 4.3
- Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.Clin Infect Dis · 201824 citationsRCR 1.1